160 related articles for article (PubMed ID: 25788917)
1. LOTUS, a potent blocker of Nogo receptor-1 causing inhibition of axonal growth.
Kurihara Y; Takei K
Neural Regen Res; 2015 Jan; 10(1):46-8. PubMed ID: 25788917
[No Abstract] [Full Text] [Related]
2. Nogo receptor antagonist LOTUS exerts suppression on axonal growth-inhibiting receptor PIR-B.
Kurihara Y; Takai T; Takei K
J Neurochem; 2020 Nov; 155(3):285-299. PubMed ID: 32201946
[TBL] [Abstract][Full Text] [Related]
3. LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand.
Kurihara Y; Iketani M; Ito H; Nishiyama K; Sakakibara Y; Goshima Y; Takei K
Mol Cell Neurosci; 2014 Jul; 61():211-8. PubMed ID: 25034269
[TBL] [Abstract][Full Text] [Related]
4. The Soluble Form of LOTUS inhibits Nogo Receptor-Mediated Signaling by Interfering with the Interaction Between Nogo Receptor Type 1 and p75 Neurotrophin Receptor.
Kawakami Y; Kurihara Y; Saito Y; Fujita Y; Yamashita T; Takei K
J Neurosci; 2018 Mar; 38(10):2589-2604. PubMed ID: 29440387
[TBL] [Abstract][Full Text] [Related]
5. Axonal branching in lateral olfactory tract is promoted by Nogo signaling.
Iketani M; Yokoyama T; Kurihara Y; Strittmatter SM; Goshima Y; Kawahara N; Takei K
Sci Rep; 2016 Dec; 6():39586. PubMed ID: 28000762
[TBL] [Abstract][Full Text] [Related]
6. The soluble form of LOTUS inhibits Nogo receptor type 1-mediated signaling induced by B lymphocyte stimulator and chondroitin sulfate proteoglycans.
Kawakami Y; Saito Y; Nakagawa R; Kurihara Y; Takei K
Neurosci Lett; 2018 Sep; 683():61-68. PubMed ID: 29953923
[TBL] [Abstract][Full Text] [Related]
7. Regulation of axonal regeneration by the level of function of the endogenous Nogo receptor antagonist LOTUS.
Hirokawa T; Zou Y; Kurihara Y; Jiang Z; Sakakibara Y; Ito H; Funakoshi K; Kawahara N; Goshima Y; Strittmatter SM; Takei K
Sci Rep; 2017 Sep; 7(1):12119. PubMed ID: 28935984
[TBL] [Abstract][Full Text] [Related]
8. Axonal regeneration and functional recovery driven by endogenous Nogo receptor antagonist LOTUS in a rat model of unilateral pyramidotomy.
Ueno R; Takase H; Suenaga J; Kishimoto M; Kurihara Y; Takei K; Kawahara N; Yamamoto T
Exp Neurol; 2020 Jan; 323():113068. PubMed ID: 31629859
[TBL] [Abstract][Full Text] [Related]
9. Blockade of chondroitin sulfate proteoglycans-induced axonal growth inhibition by LOTUS.
Kurihara Y; Saito Y; Takei K
Neuroscience; 2017 Jul; 356():265-274. PubMed ID: 28571719
[TBL] [Abstract][Full Text] [Related]
10. Cartilage acidic protein-1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation.
Sato Y; Iketani M; Kurihara Y; Yamaguchi M; Yamashita N; Nakamura F; Arie Y; Kawasaki T; Hirata T; Abe T; Kiyonari H; Strittmatter SM; Goshima Y; Takei K
Science; 2011 Aug; 333(6043):769-73. PubMed ID: 21817055
[TBL] [Abstract][Full Text] [Related]
11. LOTUS Inhibits Neuronal Apoptosis and Promotes Tract Regeneration in Contusive Spinal Cord Injury Model Mice.
Ito S; Nagoshi N; Tsuji O; Shibata S; Shinozaki M; Kawabata S; Kojima K; Yasutake K; Hirokawa T; Matsumoto M; Takei K; Nakamura M; Okano H
eNeuro; 2018; 5(5):. PubMed ID: 30560203
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor (BDNF) induces antagonistic action to Nogo signaling by the upregulation of lateral olfactory tract usher substance (LOTUS) expression.
Matsubayashi J; Kawaguchi Y; Kawakami Y; Takei K
J Neurochem; 2023 Jan; 164(1):29-43. PubMed ID: 36448220
[TBL] [Abstract][Full Text] [Related]
13. The carboxyl-terminal region of Crtac1B/LOTUS acts as a functional domain in endogenous antagonism to Nogo receptor-1.
Kurihara Y; Arie Y; Iketani M; Ito H; Nishiyama K; Sato Y; Nakamura F; Mizuki N; Goshima Y; Takei K
Biochem Biophys Res Commun; 2012 Feb; 418(2):390-5. PubMed ID: 22281491
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation.
Takahashi K; Takeuchi H; Kurihara Y; Doi H; Kunii M; Tanaka K; Nakamura H; Fukai R; Tomita-Katsumoto A; Tada M; Higashiyama Y; Joki H; Koyano S; Takei K; Tanaka F
J Neuroinflammation; 2018 Feb; 15(1):46. PubMed ID: 29454354
[TBL] [Abstract][Full Text] [Related]
15. Cyclic-AMP induces Nogo-A receptor NgR1 internalization and inhibits Nogo-A-mediated collapse of growth cone.
Gopalakrishna R; Mades A; Oh A; Zhu A; Nguyen J; Lin C; Kindy MS; Mack WJ
Biochem Biophys Res Commun; 2020 Mar; 523(3):678-684. PubMed ID: 31948754
[TBL] [Abstract][Full Text] [Related]
16. Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis.
Takahashi K; Kurihara Y; Suzuki Y; Goshima Y; Tanaka F; Takei K
JAMA Neurol; 2015 Feb; 72(2):176-9. PubMed ID: 25437093
[TBL] [Abstract][Full Text] [Related]
17. LOTUS, an endogenous Nogo receptor antagonist, is involved in synapse and memory formation.
Nishida R; Kawaguchi Y; Matsubayashi J; Ishikawa R; Kida S; Takei K
Sci Rep; 2021 Mar; 11(1):5085. PubMed ID: 33658590
[TBL] [Abstract][Full Text] [Related]
18. LOTUS as an endogenous protein converting the adult central nervous system environment from nonpermissive to permissive for axonal regrowth after brain injury.
Takei K
Neuropathology; 2020 Feb; 40(1):14-20. PubMed ID: 31908040
[TBL] [Abstract][Full Text] [Related]
19. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
GrandPré T; Li S; Strittmatter SM
Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
[TBL] [Abstract][Full Text] [Related]
20. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration.
Fournier AE; GrandPre T; Strittmatter SM
Nature; 2001 Jan; 409(6818):341-6. PubMed ID: 11201742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
